PARD 2.14 (NASD) $heff Portfolio Holding on watch as undervalued big board biotech play w/a big conference this weekend where they present a poster discussing Phase II data in colon cancer. This is a forward-looking play. $heff stockcharts.com/c-sc/sc?s=pard&p=D&yr=0&mn=9&dy=0&i=p93834726544&r=3658